Clinical Trials Logo

Neuropathic Pain clinical trials

View clinical trials related to Neuropathic Pain.

Filter by:

NCT ID: NCT01776749 Completed - Low Back Pain Clinical Trials

Subcutaneous Stimulation as Add on Therapy to SCS toTreat Low Back Pain in FBSS

SubQ
Start date: November 9, 2011
Phase: N/A
Study type: Interventional

Aim of the study Failed back surgery syndrome (FBSS) is a clinical entity consisting of chronic leg and /or back pain due to radicular nerve damage. The effectiveness of Spinal Cord Stimulation (SCS) in the pain management of patients with FBSS is proven. Patients mostly have dominant leg pain, however a significant percentage of FBSS patients has a more pronounced back pain and are commonly excluded from SCS as it is often inadequate in relieving both the back and leg pain components. Recently some reports showed the benefit of subcutaneous stimulation (SubQ) for low back pain in patients with FBSS. This has been confirmed by a feasibility study performed by our group. The aim of the randomized controlled study is to evaluate the effect of SubQ on low back pain in FBSS patients for whom SCS gives an inadequate back pain relief. Hypothesis We hypothesize that SubQ in addition to SCS in FBSS patients with leg and low back pain is more effective in treating low back pain (i.e. >50% pain reduction) than SCS alone.

NCT ID: NCT01755546 Completed - Osteoarthritis Clinical Trials

Long-term Open-Label Safety Study to Evaluate EN3409

Start date: December 2012
Phase: Phase 3
Study type: Interventional

The purpose of the long-terms study is to evaluate the safety, tolerability, and analgesic efficacy of EN3409 in subjects with moderate to severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.

NCT ID: NCT01752322 Completed - Pain Clinical Trials

Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain

Start date: October 2012
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to investigate the efficacy and safety of lidocaine 5% medicated plaster in localized chronic post-operative neuropathic pain in comparison to placebo plaster.

NCT ID: NCT01733277 Completed - Knee Osteoarthritis Clinical Trials

Osteoarthritis Structural Changes Assessed by Magnetic Resonance Imaging and Neuropathic Pain in Knee Osteoarthritis

Start date: January 2013
Phase: N/A
Study type: Observational

The primary objective of this study is to identify osteoarthritis (OA) structural changes, as assessed by MRI, that best correlate with the presence of neuropathic pain (NP) using the PainDETECT questionnaire (PainDETECT ≥ 13) on a population of patients with OA of the knee experiencing moderate to severe pain (VAS ≥ 40 mm).

NCT ID: NCT01718821 Completed - Depression Clinical Trials

Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients

Start date: September 2012
Phase: N/A
Study type: Observational

Pain is one of the most common symptoms associated with cancer. The approach to pain management compresses routine pain assessments, utilizes both pharmacologic and nonpharmacologic interventions, and requires ongoing reevaluation of the patient. Cancer pain can be well controlled in the vast majority of patients if the algorithms of pain control are systematically applied, carefully monitored, and tailored to the needs of the individual patient.This study is aimed to assess the current pain managements in upper gastrointestinal cancer patients in Taiwan. The effects of neuropathic pain and depression on the enrolled patients would also be assessed.

NCT ID: NCT01705626 Completed - Neuropathic Pain Clinical Trials

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)

TRAP2-1
Start date: December 2016
Phase:
Study type: Observational

An International, multicenter, epidemiological observational study investigating the prevalence of Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR-FAP) in participants with small fiber polyneuropathy of no obvious etiology.

NCT ID: NCT01701362 Completed - Neuropathic Pain Clinical Trials

Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain

Start date: October 2012
Phase: Phase 3
Study type: Interventional

This study is designed to investigate if pregabalin is effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma due to a traumatic or surgical event such as, for example, motor vehicle accident, fall, sports injury, knee or hip replacement, hernia repair, thoracotomy, mastectomy, focal/localized burns or crush injury.

NCT ID: NCT01669967 Completed - Neuropathic Pain Clinical Trials

The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin

Start date: September 2011
Phase: N/A
Study type: Interventional

Pain as a result of nerve injury (neuropathic pain) is a particularly severe form of chronic pain. Common examples of neuropathic pain are pain due to diabetes and shingles. There is good evidence that an intravenous infusion of lidocaine (local anesthetic) is useful for the management of neuropathic pain in the short term - up to six hours.

NCT ID: NCT01633086 Completed - Neuropathic Pain Clinical Trials

A Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Painful Diabetic Neuropathy

Start date: July 2012
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, 2-period crossover, 12-week trial to be conducted in 50 subjects with painful diabetic neuropathy. The objective of this trial is to assess the safety and efficacy of NO gel, a NO donor, as compared with a placebo gel, in symptom relief of subjects with painful diabetic neuropathy.

NCT ID: NCT01604265 Completed - Multiple Sclerosis Clinical Trials

A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis

Start date: March 2002
Phase: Phase 3
Study type: Interventional

To investigate the ability of Sativex to relieve central neuropathic pain in multiple sclerosis subjects.